pISSN 1226-6051
eISSN 2508-786X

Table. 1.

Table. 1.

Common terminology criteria for adverse events version 5.0

Grade IGrade IIGrade IIIGrade IV
Creatinine increased>ULNe-1.5 x ULN>1.5-3.0 x baseline>3.0 x baseline>6.0 x ULN
ASTa increased>ULN-3.0 x ULN>3.0-5.0 x ULN>5.0-20.0 x ULN>20.0 x ULN
ALTb increased>ULN-3.0 x ULN>3.0-5.0 x ULN>5.0-20.0 x ULN>20.0 x ULN

WBCc decreased (103/μL)< LLNf-3.0< 3.0-2.0< 2.0-1.0< 1.0
ANCd decreased (103/μL)< LLN-1.5< 1.5-1.0< 1.0-0.5< 0.5
Platelet decreased (103/μL)< LLN-75.0< 75.0-50.0< 50.0-25.0< 25.0
Anemia (Hemoglobin, g/dL)< LLN-10.0< 10.0-8.0< 8.0Life-threatening

Aspartate aminotransferase

Alanine aminotransferase

White blood cell

Absolute neutrophil count

Upper limit of normal

Lower limit of normal

Korean J Clin Pharm 2019;29:101-8 https://doi.org/10.24304/kjcp.2019.29.2.101
© 2019 Korean J Clin Pharm